Reply to Bush and Kaye

Clin Infect Dis. 2017 Oct 16;65(9):1596. doi: 10.1093/cid/cix531.

Authors

Ravina Kullar¹, Debra A Goff², Karri A Bauer¹, Thomas M File Jr^{3

4}

Affiliations

¹ MRL, Merck & Co, Inc, Kenilworth, New Jersey.
² Wexner Medical Center, College of Pharmacy, Ohio State University, Columbus.
³ Northeast Ohio Medical University.
⁴ Division of Infectious Disease, Summa Health, Akron, Ohio.

PMID: 28591832
DOI: 10.1093/cid/cix531

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Bacterial Agents
Anti-Infective Agents*
Pulmonary Artery

Substances

Anti-Bacterial Agents
Anti-Infective Agents